Newport Beach Medicaid providers billed $606,949 for COVID-19 care in 2024

Dr. Mehmet Oz CMS Administrator
Dr. Mehmet Oz CMS Administrator
0Comments

In 2024, Medicaid providers in Newport Beach submitted claims totaling at least $606,949 for health care services classified under HCPCS codes associated with COVID-19, based on data from the U.S. Department of Health and Human Services Medicaid Provider Spending database.

Medicaid operates as a state-administered public health insurance program with combined funding from federal and state sources. Covering low-income families and individuals, seniors, children, and people with disabilities, it forms one of the largest segments of the U.S. health care system. More information can be found through the Commonwealth Fund.

As Medicaid spending relies on taxpayer dollars, changes in local claims provide a picture of how community funds are directed toward public health care.

This assessment identified COVID-19–specific services by targeting HCPCS billing codes marked as “COVID-19” or “coronavirus”-related in claims descriptions or analytic reference lists. Therefore, the overall totals in the figures represent strictly COVID-labeled billing and exclude health care targeted more broadly under other code categories.

San Jose, for comparison, had the highest Medicaid COVID-related billing for services in California for 2024, with cumulative claims reaching $5,601,479.

In Newport Beach, five Medicaid providers filed COVID-19–related claims in 2024. The code labeled COVID Specific made up the bulk of this billing at $427,780.

The average Medicaid billing per provider in Newport Beach for COVID-19–associated services was $121,390, higher than California’s average of $52,976 per provider.

COVID-19–labeled services contributed heavily to Medicaid payment growth in Newport Beach during the pandemic period.

Across other categories of Medicaid claims, payments jumped by $20,616,011 from 2020 to 2024, for a growth rate of 135.3%.

In the two years ahead of the pandemic, annual Medicaid payments in Newport Beach averaged $12,084,715.

According to the Centers for Medicare & Medicaid Services, total spending by federal and state governments on Medicaid was approximately $871.7 billion for fiscal year 2023, which represented about 18% of U.S. health expenditures nationally. That’s a significant rise from $613.5 billion in 2019, before the COVID-19 outbreak began.

This marks an increase of about 40% over just a few years, mainly due to expanded program enrollment and greater service use during and following the pandemic.

Recent federal legislative actions during the Trump administration contain major plans to decrease federal Medicaid funding and alter the program’s structure. For example, the “One Big Beautiful Bill Act,” signed in 2025, is expected to trim federal Medicaid expenditures by more than $1 trillion in the next 10 years, and introduces new policies like work requirements and higher cost-sharing. These changes could mean reduced coverage and additional funding responsibilities for states, even as Medicaid continues supporting millions nationwide.

Medicaid Payments in Newport Beach Over 7 Years
Year COVID-19–Related Payments COVID-19 Payments % Change (YoY) Total Medicaid Payments
2024 $606,949 -37.9% $36,463,164
2023 $976,685 -87.7% $31,174,967
2022 $7,914,987 274.9% $29,848,246
2021 $2,110,958 401.1% $22,622,750
2020 $421,226 N/A $15,661,430
2019 $0 N/A $13,663,601
2018 $0 N/A $10,505,829
Top COVID-19–Related HCPCS Codes in Newport Beach
HCPCS Code Description Medicaid Payments Claims
87635 COVID Specific $427,780 18,402
87811 Immunoassay $179,168 7,161

Note: Includes HCPCS codes explicitly labeled for COVID-19 services; totals do not represent all pandemic-related health care spending.

This report uses information from the U.S. Department of Health and Human Services Medicaid Provider Spending database. Source data are available here.



Related

Dave Min, U.S. Representative of California's 47th Congressional District

House bill proposes mandatory harassment reporting programs for major transit agencies

Rep. Dave Min introduced a bill in the House aimed at strengthening passenger harassment reporting procedures and data collection within public transit systems, seeking to address and better track incidents.

Jim Traficant, Chief of Staff of FDA

FDA cites Boscogen, Inc. in Irvine for 4 violations during April 21 inspection

The Food and Drug Administration inspected Boscogen, Inc. in Irvine on April 21, issuing four citations related to food composition, standards, labeling and econ, according to the FDA’s official website.

Sara Brenner, Principal Deputy Commissioner at FDA

FDA reviews Fina International, Inc. in Tustin during April 28 inspection

On April 28, the FDA conducted a foodborne biological hazard inspection at Fina International, Inc. in Tustin, according to information on the agency’s website.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Central OC Times.